Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.

导出 OA

翻译打印收藏纠错

第一作者： Cara,Haymaker

第一单位： Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

作者： Cara,Haymaker ^[1] ; Daniel H,Johnson ^[2] ; Ravi,Murthy ^[3] ; Salah-Eddine,Bentebibel ^[2] ; Marc I,Uemura ^[2] ; Courtney W,Hudgens ^[1] ; Houssein,Safa ^[2] ; Marihella,James ^[2] ; Robert H I,Andtbacka ^[4] ; Douglas B,Johnson ^[5] ; Montaser,Shaheen ^[6] ; Michael A,Davies ^[2] ; Shah,Rahimian ^[7] ; Srinivas K,Chunduru ^[7] ; Denái R,Milton ^[8] ; Michael T,Tetzlaff ^[1] ; Willem W,Overwijk ^[9] ; Patrick,Hwu ^[2] ; Nashat,Gabrail ^[2] ; Sudhir,Agrawal ^[10] ; Gary,Doolittle ^[11] ; Igor,Puzanov ^[12] ; Joseph,Markowitz ^[13] ; Chantale,Bernatchez ^[14] ; Adi,Diab ^[15]

作者单位： Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[3] Surgical Oncology Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. ^[4] Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. ^[5] Department of Medicine and Cancer Center, University of Arizona, Tucson, Arizona. ^[6] Idera Pharmaceuticals, Inc., Exton, Pennsylvania. ^[7] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[8] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[9] Department of Oncology, Gabrail Cancer Center, Canton, Ohio. ^[10] Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts. ^[11] Department of Oncology, University of Kansas Medical Center, Kansas City, Kansas. ^[12] Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York. ^[13] Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ^[14] Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. adiab@mdanderson.org cbernatchez@mdanderson.org. ^[15]